CRISPR Therapeutics $2.4 Billion Cash: Why the Stock Slump Persists
CRISPR Therapeutics wields a rare card: a cash-rich balance sheet and an approved gene therapy. But the stock refuses...
Budgeting mistakes can derail your financial goals. Learn what not to do in budgeting and set yourself up for financial success.
26,044 articlesCRISPR Therapeutics wields a rare card: a cash-rich balance sheet and an approved gene therapy. But the stock refuses...
May data show mortgage credit availability edges higher, led by a small loosening in jumbo loan programs despite high...
SpaceX aims to push humanity beyond Earth, and its IPO could redefine tech investing. This guide breaks down how mult...
A bipartisan House bill seeks to cut red tape in Buy America housing funding, aiming to speed projects that rely on H...
SpaceX is the talk of Wall Street, but a rush to buy at the IPO could be reckless. This guide explains why waiting fo...
Aurora Cannabis faces a pivotal year in 2026. This guide breaks down what to expect in aurora (acb) 2026 earnings, ho...
Retirees face a tricky balance: grow their nest egg while ensuring steady withdrawals. A smarter rebalance retirement...
A couple aged 66 with $2.2M discovers hidden spending during a retirement audit, challenging their withdrawal strateg...
June can feel like a turning point for people nearing retirement. This riskiest times year demands careful planning a...
The latest monthly gauge shows a sharper-than-expected slowdown in manufacturing, fueling investor caution as the pat...
A 63-year-old, single worker faces the classic Social Security dilemma: claim now for $1,750 monthly or delay to 70 f...
When Congress tackles Social Security's funding challenges, the sting is felt far beyond retirees. This article break...